drugset / Trial / NCT07053852
Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
NaSingle-groupOpen-labelTreatment
Summary
To provide a treatment of both actinic keratoses and photodamage within one treatment.
Timeline
- Start
- 2025-06-27
- Primary completion
- 2025-12-29
- Completion
- 2025-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aminolevulinic Acid | Diagnostic / imaging agent | — | — |